메뉴 건너뛰기




Volumn 52, Issue 2, 2007, Pages 597-599

Adjuvant Therapy with Sorafenib in Bone Metastases Bilateral Renal Carcinoma: A Case Report{A figure is presented}

Author keywords

Cytoreductive nephrectomy; Kinase inhibitor; Metastatic renal cell carcinoma; Multitargeted tyrosine

Indexed keywords

ALPHA INTERFERON; ANALGESIC AGENT; INTERLEUKIN 2; SORAFENIB;

EID: 34250705317     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.083     Document Type: Short Survey
Times cited : (10)

References (3)
  • 1
    • 33947262990 scopus 로고    scopus 로고
    • Sorafenib: in advanced renal cancer
    • McKeage K., and Walstaff A.J. Sorafenib: in advanced renal cancer. Drugs 67 (2007) 475-483
    • (2007) Drugs , vol.67 , pp. 475-483
    • McKeage, K.1    Walstaff, A.J.2
  • 2
    • 33744921863 scopus 로고    scopus 로고
    • Dendritic cells for the treatment of metastatic renal cell carcinoma: at a low ebb?
    • Patard J.-J. Dendritic cells for the treatment of metastatic renal cell carcinoma: at a low ebb?. Eur Urol 50 (2006) 11-13
    • (2006) Eur Urol , vol.50 , pp. 11-13
    • Patard, J.-J.1
  • 3
    • 33847706486 scopus 로고    scopus 로고
    • Novel targets and therapies for metastatic renal cell carcinoma
    • Feldman D.R., and Motzer R.J. Novel targets and therapies for metastatic renal cell carcinoma. Oncology 20 (2006) 1745-1753
    • (2006) Oncology , vol.20 , pp. 1745-1753
    • Feldman, D.R.1    Motzer, R.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.